Previous close | 0.8000 |
Open | 0.7000 |
Bid | 0.4500 |
Ask | 1.9500 |
Strike | 22.50 |
Expiry date | 2024-05-17 |
Day's range | 0.7000 - 0.7000 |
Contract range | N/A |
Volume | |
Open interest | 100 |
Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that members of the Syndax management team will participate in a fireside chat at the Bank of America Securities 2024 Health Care Conference on Thursday, May 16, 2024, at 8:00 a.m. PT/ 11:00 a.m. ET.
Insights into SNDX's robust pipeline progress, financial health, and strategic plans for upcoming drug launches.
Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today reported its financial results for the quarter ended March 31, 2024, and provided a business update.